Hyperfine Research Inc. and Penn Medicine have teamed up to test out the world’s first portable MRI system. The clinical research study aims to look at whether the Hyperfine portable MRI machine can compete with the high-field MRI machines that are currently in use through several rounds of clinical studies.
In essence, the main goal of Hyperfine’s portable MRI system is to allow for any patients to receive an MRI without leaving their hospital bed while allowing doctors access to real-time images and monitoring. Additionally, the lower-cost allows for more patients and clinical settings to have access to an MRI machine. The device is pending in the FDA as a 510(k).
What Is Hydrocephalus?
Hydrocephalus is a possibly fatal condition in which there’s a buildup of cerebrospinal fluid within the brain. A person with hydrocephalus will experience various symptoms such as dizziness, headaches, gait complications, and varying cognitive impairments. Hydrocephalus could even lead to death in the most severe cases, but the new Hyperfine MRI device could bring significant advancements in monitoring and treating patients with this condition.